Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,107 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects

NCT07480824

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: The First Affiliated Hospital of Henan University of Science & Technology Luoyang, Henan, China

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital) Jinan, Shandong, China

View Trial Details

Recruiting

A Telehealth Advance Care Planning Intervention

NCT05875805

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +13 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations: University of Michigan ( Site 6000) Ann Arbor, Michigan, United States

DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States

UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States

View all 21 locations

View Trial Details

Recruiting

A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia

NCT06368414

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations: Gachon University Gil Medical Center Incheon, South Korea

View Trial Details

Recruiting

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

NCT05304377

Conditions: Bone Marrow Diseases, CML, Chronic Disease, +14 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

Montefiore Medical Center The Bronx, New York, United States

Oregon Health & Science University-Knight Cardiovascular Institute Portland, Oregon, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View all 45 locations

View Trial Details

Recruiting

Momelotinib During and After HCT in Myelofibrosis

NCT07104799

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematopoietic Cell Transplantation (HCT), +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia

NCT07071155

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Recruiting

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

NCT06063486

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +17 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

NCT06093672

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Emad Ibrahim, MD, Inc Redlands, California, United States

US Oncology Inc Englewood, Colorado, United States

American Oncology Partners of Maryland, PA Bethesda, Maryland, United States

View all 90 locations

View Trial Details

Recruiting

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

NCT03533816

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations: University of Kansas Cancer Center Westwood, Kansas, United States

Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions